On Jul 22, 2026, MEDP reported earnings of 4.25 USD per share (EPS) for Q2 26, beating the estimate of 4.05 USD, resulting in a 4.93% surprise. Revenue reached 707.33 million, compared to an expected 701.40 million, with a 0.85% difference. The market reacted with a +14.71% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 4.50 USD, with revenue projected to reach 728.59 million USD, implying an increase of 5.88% EPS, and increase of 3.01% in Revenue from the last quarter.